TW200833670A - Novel compounds 569 - Google Patents

Novel compounds 569

Info

Publication number: TW200833670A
Authority: TW; Taiwan
Prior art keywords: novel compounds; therapy; processes; formula; preparation
Prior art date: 2006-12-20

Application number

TW096146813A

Other languages

English (en)

Inventor

Stephen Connolly

Alexander Humphries

Premji Meghani

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-20

Filing date

2007-12-07

Publication date

2008-08-16

2007-12-07 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2008-08-16 Publication of TW200833670A publication Critical patent/TW200833670A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Steroid Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TW096146813A 2006-12-20 2007-12-07 Novel compounds 569 TW200833670A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US87092206P	2006-12-20	2006-12-20
US91004507P	2007-04-04	2007-04-04
US95198007P	2007-07-26	2007-07-26

Publications (1)

Publication Number	Publication Date
TW200833670A true TW200833670A (en)	2008-08-16

Family

ID=39167020

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW096146813A TW200833670A (en)	2006-12-20	2007-12-07	Novel compounds 569

Country Status (20)

Country	Link
US (3)	US20100022491A1 (zh)
EP (1)	EP2121642B1 (zh)
JP (1)	JP2010513440A (zh)
KR (1)	KR20090091342A (zh)
AR (1)	AR064635A1 (zh)
AT (1)	ATE517879T1 (zh)
AU (1)	AU2007336075B2 (zh)
BR (1)	BRPI0722096A2 (zh)
CA (1)	CA2672811A1 (zh)
CL (1)	CL2007003765A1 (zh)
CO (1)	CO6190554A2 (zh)
EC (1)	ECSP099426A (zh)
IL (1)	IL199014A0 (zh)
MX (1)	MX2009006009A (zh)
NO (1)	NO20092691L (zh)
PE (1)	PE20081544A1 (zh)
SA (1)	SA07280728B1 (zh)
TW (1)	TW200833670A (zh)
UY (1)	UY30808A1 (zh)
WO (1)	WO2008075026A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200738658A (en) *	2005-08-09	2007-10-16	Astrazeneca Ab	Novel compounds
TW200738659A (en) *	2005-08-29	2007-10-16	Astrazeneca Ab	Novel compounds
TW200745067A (en) *	2006-03-14	2007-12-16	Astrazeneca Ab	Novel compounds
TW200825084A (en)	2006-11-14	2008-06-16	Astrazeneca Ab	New compounds 521
TW200833670A (en) *	2006-12-20	2008-08-16	Astrazeneca Ab	Novel compounds 569
GB0702458D0 (en) *	2007-02-08	2007-03-21	Astrazeneca Ab	Salts 668
JP4837800B2 (ja)	2008-05-13	2011-12-14	アストラゼネカ・アクチエボラーグ	ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
CN102908624A (zh) *	2008-05-13	2013-02-06	阿斯利康(瑞典)有限公司	包含毒蕈碱性受体拮抗剂和β2-肾上腺素受体激动剂的药物产品
CN102124003A (zh)	2008-06-18	2011-07-13	阿斯利康(瑞典)有限公司	作为治疗呼吸系统疾病的β2肾上腺素受体拮抗剂的苯并噁嗪酮衍生物
JP2011524897A (ja) *	2008-06-20	2011-09-08	アストラゼネカ・アクチエボラーグ	β２−アドレナリン受容体活性の調節のための、４−ヒドロキシ−２−オキソ−２，３−ジヒドロ−１，３−ベンゾチアゾール−７−イル化合物を含む医薬組成物
GB0814728D0 (en) *	2008-08-12	2008-09-17	Argenta Discovery Ltd	New combination
TW201036957A (en)	2009-02-20	2010-10-16	Astrazeneca Ab	Novel salt 628
GB0913342D0 (en)	2009-07-31	2009-09-16	Astrazeneca Ab	Compounds - 801
WO2011061527A1 (en)	2009-11-17	2011-05-26	Astrazeneca Ab	Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
GB201016912D0 (en)	2010-10-07	2010-11-24	Astrazeneca Ab	Novel combination
JO3192B1 (ar)	2011-09-06	2018-03-08	Novartis Ag	مركب بنزوثيازولون
US9353078B2 (en) *	2013-10-01	2016-05-31	New York University	Amino, amido and heterocyclic compounds as modulators of rage activity and uses thereof

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2653977A (en)		1953-09-29		Chxnx
US3775477A (en)	1971-03-10	1973-11-27	Sterling Drug Inc	N,n'-bis(2-aryl-2-(hydroxy or oxo)-ethyl)-bridged-bis-carboxamides
US4460581A (en)	1982-10-12	1984-07-17	Boehringer Ingelheim Kg	(1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3571808D1 (en)	1984-04-17	1989-08-31	Glaxo Group Ltd	Ethanolamine compounds
US4554287A (en)	1984-09-12	1985-11-19	Smithkline Beckman Corporation	Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
US4554284A (en)	1984-09-12	1985-11-19	Smithkline Beckman Corporation	7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
GB8525483D0 (en)	1985-10-16	1985-11-20	Glaxo Group Ltd	Chemical compounds
GB8718938D0 (en)	1987-08-11	1987-09-16	Glaxo Group Ltd	Chemical compounds
PT95542B (pt)	1989-10-10	1999-09-30	Glaxo Group Ltd	Processo para a prparacao de derivados de fenetanolamina
IE914003A1 (en)	1990-11-20	1992-05-20	Astra Pharma Prod	Biologically Active Amines
GB9211172D0 (en)	1992-05-27	1992-07-08	Fisons Plc	Compounds
GB9210632D0 (en)	1992-05-19	1992-07-01	Fisons Plc	Compounds
US5648370A (en)	1990-11-20	1997-07-15	Astra Pharmaceuticals Limited	7-(2-aminoethyl) benzothiazolones
TW356468B (en) *	1995-09-15	1999-04-21	Astra Pharma Prod	Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same
GB9526511D0 (en)	1995-12-23	1996-02-28	Astra Pharma Prod	Pharmaceutically active compounds
WO1997044329A1 (en)	1996-05-20	1997-11-27	Teijin Limited	Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
SE9700706D0 (sv)	1997-02-27	1997-02-27	Astra Pharma Prod	Process for the preparation of benzothiazoline compounds
SE9701304D0 (sv)	1997-04-09	1997-04-09	Astra Pharma Prod	Compounds
WO1999036095A1 (en)	1998-01-13	1999-07-22	Astrazeneca Uk Limited	PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND HAVING DOPAMINE (D2) RECEPTOR AGONIST ACTIVITY AND A COMPOUND (B) HAVING β2-ADRENORECEPTOR AGONIST ACTIVITY
US6362371B1 (en)	1998-06-08	2002-03-26	Advanced Medicine, Inc.	β2- adrenergic receptor agonists
GB9913083D0 (en)	1999-06-04	1999-08-04	Novartis Ag	Organic compounds
US6683115B2 (en)	1999-06-02	2004-01-27	Theravance, Inc.	β2-adrenergic receptor agonists
SE9902935D0 (sv)	1999-08-18	1999-08-18	Astra Pharma Prod	Pharmaceutical compositions
SE9902936D0 (sv)	1999-08-18	1999-08-18	Astra Pharma Prod	Pharmaceutical compositions
SE9902937D0 (sv)	1999-08-18	1999-08-18	Astra Pharma Prod	Pharmaceutical compositions
SE9902938D0 (sv)	1999-08-18	1999-08-18	Astra Pharma Prod	Pharmaceutical compositions
OA11558A (en)	1999-12-08	2004-06-03	Advanced Medicine Inc	Beta 2-adrenergic receptor agonists.
US6506901B2 (en)	2000-07-17	2003-01-14	Wyeth	Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonists
US7045658B2 (en)	2001-03-22	2006-05-16	Glaxo Group Limited	Formailide derivatives as beta2-adrenoreceptor agonists
BRPI0212455B8 (pt)	2001-09-14	2021-05-25	Glaxo Group Ltd	composto derivado de fenetanolamina para o tratamento de doenças respiratórias, formulação farmacêutica, combinação, e, uso do mesmo
US20030229058A1 (en)	2001-11-13	2003-12-11	Moran Edmund J.	Aryl aniline beta2 adrenergic receptor agonists
GB0217225D0 (en)	2002-07-25	2002-09-04	Glaxo Group Ltd	Medicinal compounds
AR040962A1 (es) *	2002-08-09	2005-04-27	Novartis Ag	Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
GB0225540D0 (en)	2002-11-01	2002-12-11	Glaxo Group Ltd	Medicinal compounds
GB0303396D0 (en)	2003-02-14	2003-03-19	Glaxo Group Ltd	Medicinal compounds
PE20040950A1 (es)	2003-02-14	2005-01-01	Theravance Inc	DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
EP1615881A2 (en)	2003-04-01	2006-01-18	Theravance, Inc.	Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200526547A (en)	2003-09-22	2005-08-16	Theravance Inc	Amino-substituted ethylamino β2 adrenergic receptor agonists
GB0324654D0 (en)	2003-10-22	2003-11-26	Glaxo Group Ltd	Medicinal compounds
GB0324886D0 (en)	2003-10-24	2003-11-26	Glaxo Group Ltd	Medicinal compounds
JP2005187357A (ja)	2003-12-25	2005-07-14	Nippon Suisan Kaisha Ltd	選択的なβ２受容体アゴニスト活性を有するベンゾチアゾロン誘導体の製造方法
TW200531692A (en)	2004-01-12	2005-10-01	Theravance Inc	Aryl aniline derivatives as β2 adrenergic receptor agonists
GB0402797D0 (en)	2004-02-09	2004-03-10	Novartis Ag	Organic compounds
WO2005092861A1 (en)	2004-03-11	2005-10-06	Pfizer Limited	Quinolinone derivatives pharmaceutical compositions containing them and their use
EP1577306A1 (de)	2004-03-17	2005-09-21	Boehringer Ingelheim Pharma GmbH & Co.KG	Neue Benzoxazinonderivate als langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
WO2005092841A1 (en)	2004-03-23	2005-10-06	Pfizer Limited	Compounds having beta-agonist activity
WO2005110990A1 (de)	2004-05-13	2005-11-24	Boehringer Ingelheim International Gmbh	Hydroxy-substituierte benzkondensierte heterozyklen als betaagonisten zur behandlung von atemwegserkrankungen
EP1595873A1 (de)	2004-05-13	2005-11-16	Boehringer Ingelheim Pharma GmbH & Co.KG	Substituierte Cycloalkylderivate zur Behandlung von Atemswegerkrankungen
DE102004024453A1 (de)	2004-05-14	2006-01-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen
AU2005252226A1 (en)	2004-06-03	2005-12-22	Theravance, Inc.	Diamine beta2 adrenergic receptor agonists
EP1778638A1 (en)	2004-07-21	2007-05-02	Theravance, Inc.	Diaryl ether beta2 adrenergic receptor agonists
EP1778626A1 (en)	2004-08-16	2007-05-02	Theravance, Inc.	Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
WO2006023460A2 (en)	2004-08-16	2006-03-02	Theravance, Inc.	COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
EP1786762A2 (en)	2004-09-10	2007-05-23	Theravance, Inc.	Amidine substituted aryl aniline compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
EP1846374A1 (en)	2005-01-11	2007-10-24	Glaxo Group Limited	Cinnamate salts of a beta-2 adrenergic agonist
GB0511066D0 (en)	2005-05-31	2005-07-06	Novartis Ag	Organic compounds
EP1907356A2 (en)	2005-07-18	2008-04-09	Pfizer Limited	Process for the preparation of sulfonamide derivatives
TW200738658A (en) *	2005-08-09	2007-10-16	Astrazeneca Ab	Novel compounds
TW200738659A (en)	2005-08-29	2007-10-16	Astrazeneca Ab	Novel compounds
TW200740781A (en) *	2005-08-29	2007-11-01	Astrazeneca Ab	Novel compounds
US20090029958A1 (en)	2006-03-08	2009-01-29	Lilian Alcaraz	Phenethanolamine derivatives as beta2 adrenoreceptor agonists
TW200745084A (en)	2006-03-08	2007-12-16	Astrazeneca Ab	Novel compounds
TW200745067A (en)	2006-03-14	2007-12-16	Astrazeneca Ab	Novel compounds
WO2008041914A1 (en)	2006-10-06	2008-04-10	Astrazeneca Ab	5-(2-AMINO-L-HYDROXYETHYL)-8-HYDROXY-2-OXOQUINOLINE DERIVATIVES AND OTHER COMPOUNDS AS β2 -ADRENERGIC AGONISTS
AU2007336074B2 (en)	2006-12-20	2011-09-22	Astrazeneca Ab	Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases
TW200833670A (en)	2006-12-20	2008-08-16	Astrazeneca Ab	Novel compounds 569
GB0702456D0 (en)	2007-02-08	2007-03-21	Astrazeneca Ab	New combination
GB0702459D0 (en)	2007-02-08	2007-03-21	Astrazeneca Ab	Salts 669
GB0702458D0 (en)	2007-02-08	2007-03-21	Astrazeneca Ab	Salts 668
GB0702457D0 (en)	2007-02-08	2007-03-21	Astrazeneca Ab	New combination 666
GB0703999D0 (en)	2007-03-01	2007-04-11	Astrazeneca Ab	New combination 667
GB0704000D0 (en)	2007-03-01	2007-04-11	Astrazeneca Ab	Salts 670
WO2009037503A2 (en)	2007-09-18	2009-03-26	Astrazeneca Ab	New combination - 012 for the treatment of respiratory diseases
MX2010006657A (es) *	2007-12-20	2010-10-05	Astrazeneca Ab	Dispositivo y metodo para desagregar polvo 854.
JP2011524897A (ja) *	2008-06-20	2011-09-08	アストラゼネカ・アクチエボラーグ	β２−アドレナリン受容体活性の調節のための、４−ヒドロキシ−２−オキソ−２，３−ジヒドロ−１，３−ベンゾチアゾール−７−イル化合物を含む医薬組成物

2007
- 2007-12-07 TW TW096146813A patent/TW200833670A/zh unknown
- 2007-12-19 AT AT07848598T patent/ATE517879T1/de not_active IP Right Cessation
- 2007-12-19 EP EP07848598A patent/EP2121642B1/en active Active
- 2007-12-19 MX MX2009006009A patent/MX2009006009A/es active IP Right Grant
- 2007-12-19 US US12/519,552 patent/US20100022491A1/en not_active Abandoned
- 2007-12-19 UY UY30808A patent/UY30808A1/es unknown
- 2007-12-19 WO PCT/GB2007/004861 patent/WO2008075026A1/en not_active Ceased
- 2007-12-19 US US11/959,679 patent/US7700782B2/en not_active Expired - Fee Related
- 2007-12-19 CA CA002672811A patent/CA2672811A1/en not_active Abandoned
- 2007-12-19 BR BRPI0722096-0A2A patent/BRPI0722096A2/pt not_active IP Right Cessation
- 2007-12-19 AU AU2007336075A patent/AU2007336075B2/en not_active Ceased
- 2007-12-19 KR KR1020097015062A patent/KR20090091342A/ko not_active Withdrawn
- 2007-12-19 JP JP2009542202A patent/JP2010513440A/ja active Pending
- 2007-12-20 AR ARP070105801A patent/AR064635A1/es not_active Application Discontinuation
- 2007-12-20 CL CL200703765A patent/CL2007003765A1/es unknown
- 2007-12-29 SA SA7280728A patent/SA07280728B1/ar unknown
2008
- 2008-01-02 PE PE2008000009A patent/PE20081544A1/es not_active Application Discontinuation
2009
- 2009-05-27 CO CO09054440A patent/CO6190554A2/es not_active Application Discontinuation
- 2009-05-27 IL IL199014A patent/IL199014A0/en unknown
- 2009-06-15 EC EC2009009426A patent/ECSP099426A/es unknown
- 2009-07-15 NO NO20092691A patent/NO20092691L/no not_active Application Discontinuation
2010
- 2010-03-30 US US12/750,014 patent/US20100249200A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2010513440A (ja)	2010-04-30
SA07280728B1 (ar)	2010-12-01
EP2121642A1 (en)	2009-11-25
ECSP099426A (es)	2009-07-31
AR064635A1 (es)	2009-04-15
ATE517879T1 (de)	2011-08-15
US20100249200A1 (en)	2010-09-30
EP2121642B1 (en)	2011-07-27
US20100022491A1 (en)	2010-01-28
AU2007336075B2 (en)	2011-10-27
CO6190554A2 (es)	2010-08-19
NO20092691L (no)	2009-09-16
PE20081544A1 (es)	2009-01-11
UY30808A1 (es)	2008-07-31
CL2007003765A1 (es)	2008-08-22
HK1136572A1 (zh)	2010-07-02
BRPI0722096A2 (pt)	2014-04-01
CA2672811A1 (en)	2008-06-26
MX2009006009A (es)	2009-06-16
WO2008075026A1 (en)	2008-06-26
US7700782B2 (en)	2010-04-20
IL199014A0 (en)	2010-02-17
KR20090091342A (ko)	2009-08-27
US20080207698A1 (en)	2008-08-28
AU2007336075A1 (en)	2008-06-26

Publication	Publication Date	Title
TW200833670A (en)	2008-08-16	Novel compounds 569
TW200801003A (en)	2008-01-01	Novel compounds
TW200508214A (en)	2005-03-01	Novel compounds
TW200745084A (en)	2007-12-16	Novel compounds
TW200800999A (en)	2008-01-01	Novel compounds
TW200745114A (en)	2007-12-16	Novel compounds
MX2010009022A (es)	2010-09-07	Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
TW200616995A (en)	2006-06-01	Novel compounds
TW200745067A (en)	2007-12-16	Novel compounds
TW200621777A (en)	2006-07-01	New dihydropteridione derivatives, process for their manufacture and their use as medicament
SE0202133D0 (sv)	2002-07-08	Novel compounds
PT1902037E (pt)	2009-10-13	2,4-diamino-pirimidinas como inibidores de aurora
SG170069A1 (en)	2011-04-29	Quinoline derivatives
TNSN07383A1 (en)	2009-03-17	1-h-quinazoline-2,4-diones and their use as ampa-receptor ligands
TW200621262A (en)	2006-07-01	New dihydropteridione derivatives, process for their manufacture and their use as medicament
MX2009003227A (es)	2009-04-06	Moduladores de los receptores de glutamato metabotropicos 5(mglur5).
TW200738659A (en)	2007-10-16	Novel compounds
TW200738658A (en)	2007-10-16	Novel compounds
SE0302139D0 (sv)	2003-07-28	Novel compounds
TW200604197A (en)	2006-02-01	New compounds
MX2009006010A (es)	2009-06-16	Derivados de amina y su uso en enfermedades mediadas por el adrenoreceptor beta 2.
TW200716529A (en)	2007-05-01	New compounds II
TW200639156A (en)	2006-11-16	New compounds
TW200745122A (en)	2007-12-16	New compounds I
TW200635917A (en)	2006-10-16	Novel compounds